author-photo

Andre Goy

Hackensack University Medical Center
University of Texas MD Anderson Cancer Center
Rutgers University

455

Papers

18482

Citations

Citation Trend

Filter By

Papers (455) Sort By

Journal Conference Others

Long-Term (≥4 Year and ≥5 Year) Overall Survival (OS) By 12- and 24-Month Event-Free Survival (EFS): An Updated Analysis of ZUMA-1, the Pivotal Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Refractory Large B-Cell Lymphoma (LBCL)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Long-Term Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Long-Term Survival and Gradual Recovery of B Cells in Patients (Pts) with Refractory Large B Cell Lymphoma (LBCL) Treated with Axicabtagene Ciloleucel (Axi-Cel)

2021
Show All
- Source
- Cite
- Save
Citations (1)
A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies.

2021 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (0)
Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): One-Year Follow-up of ZUMA-1 Cohort 6 (C6)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Reliability of Liquid Biopsy and Next Generation Sequencing in Monitoring Residual Disease Post-Hematopoietic Stem Cell Transplant

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma: Real World Experience from the US Lymphoma CAR T Consortium

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
PK and PD Assessment of BET Inhibitor Pelabresib (CPI-0610) in Patients with Relapsed or Refractory Lymphoma: Findings from a Phase 1 Study

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Recognizing Unmet Need in the Era of Targeted Therapy for CLL/SLL: "What's Past is Prologue" (Shakespeare).

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Bone Marrow-Based Biomarkers for Predicting aGVHD Using Targeted RNA Next Generation Sequencing and Machine Learning

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)